Northwestern Medicine Fertility and Reproductive Medicine
Chicago, Illinois, 60611, United States
Location status: Recruiting
Location contact
Brianna Borger, BS
CONTACT
Emily Jungheim, MD, MSCI
CONTACT
NCT Number: NCT05358483
The goal of the PROMISE study is to determine how pre-conception lifestyle factors (e.g., sleep, nutrition, physical activity) affect short- and long-term reproductive outcomes.
Interested in participating?
Request Info18 year–44 year
Female
Observational
Chicago, Illinois, 60611, United States
Location status: Recruiting
Brianna Borger, BS
CONTACT
Emily Jungheim, MD, MSCI
CONTACT
The overall goal of the PROMISE study is to identify strategies to improve health outcomes for women and their children. The proposed study is important and novel as it aims to capture women before they are pregnant. Current research on maternal and child health often focuses on women who are already pregnant. This time period is likely too late to make a meaningful clinical impact on long term maternal and child health outcomes influenced by social and epidemiologic determinants of health as important epigenetic changes are or have already taken place. Examples of tools that will be used to capture social and epidemiologic data include validated surveys for nutrition, physical activity, sleep, and stress. The importance of these tools is that many of the data points captured are modifiable, and therefore if associations are noted between these data points and health outcomes, actionable interventions may be developed and implemented for women who are preconceptional.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: ~0-24 months
Live birth after embryo transfer (y/n)
Time frame: ~0-24 months
IVF cycle number
Time frame: ~0-24 months
Most recent AMH
Time frame: ~0-24 months
Most recent AFC
Time frame: ~0-24 months
E.g., male factor, DOR, tubal factor
Time frame: ~0-24 months
Antagonist, microcode flare, long agonist, minimal stimulation
Time frame: ~0-24 months
Total gonadotropin dose
Time frame: ~0-24 months
Maximum estradiol level
Time frame: ~0-24 months
Total number of days of stimulation
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Cycle cancellation (Y/N). If Y, reason for cancellation
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Frozen or fresh embryo transfer
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~0-24 months
ICSI, conventional, split
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Placenta accreta, Placenta previa, Placenta increta, Placenta percreta
Time frame: ~12-36 months
Time frame: ~12-36 months
Cleft palate, genetic defect, limb defect, cardiac defect, other
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
NIPT, CVS, amniocentesis
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Weight (lbs)
Time frame: ~12-36 months
Height (inches)
Time frame: ~0-24 months
Time frame: ~0-24 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Birth <37 weeks
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-36 months
Time frame: ~12-48 months
Time frame: ~12-48 months
Time frame: ~12-48 months
Time frame: ~12-48 months
Time frame: ~12-48 months
<28 days post delivery
Time frame: ~12-48 months
Time frame: ~12-48 months
Time frame: ~12-48 months
Time frame: ~12-48 months
Time frame: ~12-48 months
Time frame: ~12-48 months
Contact information is provided by the study sponsor or research team.
Brianna Borger, BS
CONTACT
Emily Jungheim, MD, MSCI
CONTACT
Northwestern University
Other
The PROMISE Study: PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
Acronym: PROMISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06686537
Body Weight, Female Urogenital Diseases
Aurora, Colorado, United States
View Trial DetailsNCT05181748
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Athens, Attica, Greece
View Trial DetailsNCT03916978
Amenorrhea, Anovulatory Infertility
Athens, Greece
View Trial DetailsNCT03951194
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Athens, Greece
View Trial Details